4-Hydroxy-4'-nitrobiphenyl → N,N-bis-(isopropyl)-2[[4'-nitro-(1,1'-biphenyl)-4-yl]oxy]-acetamide

HRID 400255

Reaktionsgleichung

Reaktionsgleichung von HRID 400255
[OH:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=2)=[CH:4][CH:3]=1.[CH:17]([N:20]([CH:25]([CH3:27])[CH3:26])[C:21](=[O:24])[CH2:22]Br)([CH3:19])[CH3:18]>>[CH:17]([N:20]([CH:25]([CH3:27])[CH3:26])[C:21](=[O:24])[CH2:22][O:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=2)=[CH:6][CH:7]=1)([CH3:19])[CH3:18]

Komponenten

3

Versuchsvorschrift

The product was prepared as in Example 2, Stage A starting with 900 mg of 4'-hydroxy-(4-nitro biphenyl) (Aldrich) and 958 mg of N,N-bis-(isopropyl)-2-bromo-acetamide (Preparation 8) to obtain 1.26 g of the expected product.

Quellen und Nachweise

ORD-Eintrag
ord-4b1bbf3a66324fc88b583320d996d174
Quelldatensatz
uspto-grants-1998_10
Patentnummer
US05827887

Verknüpfte Notizen

Wird geladen…